fregime
TODAYSTOCKSARCHIVEABOUTGUIDE
Sign inFollow your stocks

Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 22 Sep 2026

HYUNDAI, full dossier

Auto retail sales in India jumped 20% to 3 crore vehicles in the last 11 months as GST rate cuts widened affordability and pulled first-time buyers back to showrooms, top auto industry executives said.

1 publisher has reported this development. Each act of reporting is below, cited.

The record

Auto retail sales in India jumped 20% to 3 crore vehicles in the last 11 months as GST rate cuts widened affordability and pulled first-time buyers back to showrooms, top auto industry executives said.

indiatimes.com22 Sep 2026

A single act of reporting so far, corroborating sources join this record as they publish.

Hyundai Motor India

₹2,024.00

▼ -0.34%

Close (EOD), as of 1 Oct 2026 · source

Hyundai Motor India: results, dividends, orders, the full cited record →

More on Hyundai Motor India

Hyundai Motor India reported its highest-ever monthly total sales including exports in September at 77,916 units, a 10.8 per cent year-on-year growth.

2 Oct 2026 · 4 publishers

Passenger Vehicle sales in India rose approximately 21.7% year-on-year to 4.6 lakh units in September 2026.

1 Oct 2026 · 3 publishers

Passenger vehicle makers such as Maruti Suzuki, Mahindra & Mahindra and Hyundai reported double-digit growth in September, but domestic two-wheeler sales at Bajaj Auto and tractor volumes at Mahindra declined during the month.

1 Oct 2026 · 1 publisher

India’s top four carmakers reported a 30.2% sales surge to 2.1 million units in H1 FY27, driven by GST tax cuts, robust SUV demand, and hatchback recovery across Maruti, Tata, M&M, and Hyundai.

1 Oct 2026 · 1 publisher

Mahindra & Mahindra, Hyundai India and auto component suppliers including Sona Comstar are likely to benefit as tighter CAFE 3 norms support faster electrification of India's auto industry, Nomura said.

1 Oct 2026 · 1 publisher

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.